Drrx stock forecast.

Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ...Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ...Nov 8, 2023 · Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes. Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ...

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ... DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants. CUPERTINO, Calif., Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a ...

NSD:DRRX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesIt's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow …DRRX Fair Price, Target Price, vs SPY, Historical gross margin, operating margin, net margin, ROE, cash flow, revenue and EPS. Financial, growth and cost analysisConstituent Stocks. 11/10/2023 00:31:46 ET. Symbol Name Latest price Chg %Chg. AMPHAmphastar Pharmaceuticals52.4106.990+15.39%DRRXDurect0.5700.043+8.16%ENDPQ ...DS one year forecast. Drive Shack stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DS stock forecast for 2023 – 2027. Last updated: November 23, 2023. Are you interested in Drive Shack Inc. stocks prediction? ... DRRX Stock Forecast; DRQ Stock Forecast;

Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

DRRX Fair Price, Target Price, vs SPY, Historical gross margin, operating margin, net margin, ROE, cash flow, revenue and EPS. Financial, growth and cost analysisView DURECT Corporation DRRX investment & stock information. Get the latest DURECT Corporation DRRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Real time Durect (DRRX) stock price quote, stock graph, news & analysis.Nov 13, 2023 · Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ... The inventory’s buying and selling value of $2.58 and common value goal of $29.80 mirror the excessive potential of the main drug candidate – and indicate a 1,064% achieve subsequent yr. (be seen DRRX stock forecast)

Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Durect (DRRX) delivered earnings and revenue surprises of 0% and 11.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Biotech Stock Screener. The top biotech stocks list is updated daily after market close. To find low price biotech stocks, go to biotech stocks under $5. 12/1/2023. To get intraday penny stocks update (every 5-10 minutes), please signup for a free account. Symbol.Nov 8, 2023 · DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million. DRRX Stock Forecast - Is DRRX a buy or sell? Find out now with a free analysis on DURECT. Should I buy or sell DRRX? DRRX Stock Analysis - [Full Report] DRRX Chart by TradingView. Accessories Stocks Animal Stocks Biopharma Stocks Biopharmaceutical Stocks Clinic Stocks Clinical Stocks

The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...

DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.DURECT Corporation (DRRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock DURECT Corporation | Nasdaq: DRRX | Nasdaq. 814c7.BI6jUPhZQxP2Us-zYE_8YwyJgJUUYh28OS76qNcwmk4.bt2SM58MJz61Cvb7TQevD0X7 …7 Jun 2023 ... Bond & Stock Ratings · Conference Call Announcements · Contracts · Cryptocurrency · Dividends · Earnings · Earnings Forecasts & Projections ...(See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ... Biotech Stock Screener. The top biotech stocks list is updated daily after market close. To find low price biotech stocks, go to biotech stocks under $5. 12/1/2023. To get intraday penny stocks update (every 5-10 minutes), please signup for a free account. Symbol.Stock Price and Dividend Data for Durect Corp (DRRX), including dividend dates, dividend yield, company news, and key financial metrics.Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.

The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median estimate represents a...

Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...DRRX Forecast — Price Target — Prediction for 2024 USD / / / Forecast DURECT Corporation DRRXNASDAQ DRRXNASDAQ 0.6518USD +0.0318 +5.13% At close at Dec 1, 16:49 UTC-8 See on Supercharts Overview …DS one year forecast. Drive Shack stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DS stock forecast for 2023 – 2027. Last updated: November 23, 2023. Are you interested in Drive Shack Inc. stocks prediction? ... DRRX Stock Forecast; DRQ Stock Forecast;The BigBear.ai Holdings stock price fell by -3.70% on the last day (Wednesday, 29th Nov 2023) from $1.89 to $1.82. During the last trading day the stock fluctuated 10.06% from a day low at $1.79 to a day high of $1.97. The price has risen in 6 of the last 10 days but is still down by -3.19% for this period. Volume has increased on the last day ...DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66. Durect (DRRX) delivered earnings and revenue surprises of -4% and 41.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI BigBear.ai $4.05 APPH AppHarvest $0.95 DRRX Durect 5.18 AUVI Applied UV $1.13 ARDX ...The BigBear.ai Holdings stock price fell by -3.70% on the last day (Wednesday, 29th Nov 2023) from $1.89 to $1.82. During the last trading day the stock fluctuated 10.06% from a day low at $1.79 to a day high of $1.97. The price has risen in 6 of the last 10 days but is still down by -3.19% for this period. Volume has increased on the last day ...DRTT one year forecast. DIRTT Environmental Solutions stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DRTT stock forecast for 2023 – 2027. Last updated: November 25, 2023. ... Other companies stock forecasts. DRRX Stock Forecast; DRQ Stock Forecast;

The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year.Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.Earnings Date. Nov 13, 2023. Forward Dividend & Yield. N/A (1.17%) Ex-Dividend Date. N/A. 1y Target Est. 6.75. Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. spectrum pharma stocktop non qm lendersaxla stock pricedirect access brokers Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock. nasdaq bitf newself bought naturium According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis. start trading options with dollar100 The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.